论文部分内容阅读
采用多普勒超声心动图评价２０例高血压病患者口服复方降压片８周前后左室重量指数（ＬＶＭＩ）、左室流入道频谱图Ａ峰与Ｅ峰比值（Ａ／Ｅ）、Ｅ峰减速率、舒张晚期与整个舒张期的速度时间积分比（ＡＡ／ＴＡ）、Ｅ峰加速面积（ＥＡＡ）分数的变化，并与２０例卡托普利治疗组相对比。两组患者治疗后血压均降至正常。卡托普利组ＬＶＭＩ、Ａ／Ｅ、ＡＡ／ＴＡ均降低，ＥＡＡ分数升高；而复方降压片组ＬＶＭＩ和左室舒张功能指标却无同步改善，甚至部分患者ＬＶＭＩ升高，ＥＡＡ分数也有所降低。提示长期口服复方降压片治疗对左室重量及其舒张功能的上述影响可能会部分抵消降压带来的益处。
The left ventricular mass index (LVMI), the ratio of peak A to peak E (E / E) and peak E of peak of left ventricular outflow tract in 20 hypertensive patients before and after oral administration of compound antihypertensive tablets were measured by Doppler echocardiography. (AA / TA) and E-peak acceleration area (EAA) scores in the late diastolic and diastolic phases were compared with those of 20 captopril-treated groups. After treatment, blood pressure in both groups dropped to normal. Captopril group LVMI, A / E, AA / TA decreased, EAA score increased; and compound antihypertensive tablets LVMI and left ventricular diastolic function index did not improve simultaneously, and even some patients with elevated LVMI, EAA scores also have Reduced. This suggests that the above effects of long-term oral compound antihypertensive therapy on left ventricular mass and its diastolic function may partially offset the benefits of antihypertensive drugs.